FDA Approves First Non-Invasive Wearable Glucose Monitor for Diabetics in the U.S.
July 6, 2025, Washington D.C. In a major win for diabetes patients and digital health innovation, the U.S. Food and Drug Administration (FDA) has granted approval for the first non-invasive, wearable glucose monitoring device. Developed by California-based startup BioSense, the device continuously measures blood sugar levels through the skin using optical spectroscopy—eliminating the need for … Read more